MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

BACKGROUND: Methylation of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter is a favorable prognostic factor in glioblastoma patients. However, reported methylation frequencies vary significantly partly due to lack of consensus in the choice of analytical method. METHOD: We examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Håvik, Annette Bentsen, Brandal, Petter, Honne, Hilde, Dahlback, Hanne-Sofie Spenning, Scheie, David, Hektoen, Merete, Meling, Torstein Ragnar, Helseth, Eirik, Heim, Sverre, Lothe, Ragnhild A, Lind, Guro Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311573/
https://www.ncbi.nlm.nih.gov/pubmed/22390413
http://dx.doi.org/10.1186/1479-5876-10-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311573/
https://www.ncbi.nlm.nih.gov/pubmed/22390413
http://dx.doi.org/10.1186/1479-5876-10-36

Ejemplares similares